Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

  1. Bardia, A.
  2. Tolaney, S.M.
  3. Punie, K.
  4. Loirat, D.
  5. Oliveira, M.
  6. Kalinsky, K.
  7. Zelnak, A.
  8. Aftimos, P.
  9. Dalenc, F.
  10. Sardesai, S.
  11. Hamilton, E.
  12. Sharma, P.
  13. Recalde, S.
  14. Gil, E.C.
  15. Traina, T.
  16. O'Shaughnessy, J.
  17. Cortes, J.
  18. Tsai, M.
  19. Vahdat, L.
  20. Diéras, V.
  21. Carey, L.A.
  22. Rugo, H.S.
  23. Goldenberg, D.M.
  24. Hong, Q.
  25. Olivo, M.
  26. Itri, L.M.
  27. Hurvitz, S.A.
  28. Erakutsi egile guztiak +
Aldizkaria:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Argitalpen urtea: 2021

Alea: 32

Zenbakia: 9

Orrialdeak: 1148-1156

Mota: Artikulua

DOI: 10.1016/J.ANNONC.2021.06.002 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus